Emily Ostertag
Biography
Overview
Emily is an associate in the Technology Transactions Practice, within the Firm's Global M&A Group and Global IP Group. Emily has experience with a variety of transactional matters involving the development, acquisition, transfer, and licensing of intellectual property and information technology. She has represented clients in a wide range of industries, including technology, media, entertainment, oil and gas, and life sciences, among others.
Experience
Representation of Avon Protection plc, a British publicly traded manufacturer of leading respiratory, chemical, biological, radiological and nuclear (CBRN), and head protection solutions globally to militaries and first responders, in connection with its agreement to sell the assets of its Lexington, KY facility to Coorstek, Inc., a global manufacturer of advanced ceramics materials.
Representation of HighCape Capital Acquisition Corp. (NASDAQ: CAPA), a SPAC sponsored by HighCape Capital LP, a healthcare growth equity fund, in its US$1.46 billion business combination with Quantum-Si Incorporated, a pioneer in next generation semiconductor chip-based proteomics.
Representation of Zimmer Biomet Holdings, Inc. (NYSE: and SIX: ZBH), a global medical technology leader, and ZimVie Inc. (NASDAQ: ZIMV) in the spinoff of ZimVie, Zimmer Biomet's former dental and spine businesses.
